Eugene Braunwald, Pioneering Cardiologist, Dies at 96

Eugene Braunwald, a physician-scientist widely regarded as one of the defining figures in modern cardiology, died April 22 at 96. Through research that reshaped how doctors understand heart attacks, clinical trials that changed treatment standards and textbooks that trained generations of physicians, Braunwald helped transform the practice of cardiovascular medicine around the world.

His death was confirmed by family and acknowledged in tributes from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, and the European Society of Cardiology. Braunwald died in Massachusetts, according to those notices. He was born Aug. 15, 1929. A family notice said he passed away peacefully surrounded by family.

Braunwald’s significance extended far beyond academic prestige. He was central to a now-foundational idea in heart care: that a heart attack is not always an instantaneous, irreversible event, and that some threatened heart muscle can still be saved if treatment comes quickly enough. That shift helped lay the intellectual groundwork for the era of reperfusion treatment, in which blocked blood flow is restored to limit damage. He also helped move cardiology toward large randomized clinical trials and evidence-based treatment, producing research that guided the use of therapies including clot-busting drugs, ACE inhibitors after heart attack and statins.

Born in Vienna, Austria, Braunwald was a child when his family fled Nazi persecution after the 1938 Anschluss. They spent time in England before emigrating to New York in 1939. He went on to earn both an A.B. and an M.D. from New York University, completed a residency in internal medicine at Johns Hopkins Hospital and began his research career at the National Heart Institute, now the NHLBI.

In that early work, Braunwald helped establish basic concepts of heart function, including preload, afterload and contractility, terms that describe the forces affecting how the heart fills and pumps. Those studies, together with his later work on myocardial infarction, or heart attack, helped redefine the field’s understanding of how heart damage develops and how it might be limited.

Braunwald later became the founding chair of the Department of Medicine at the University of California, San Diego. From 1972 to 1996, he served as chair of the Department of Medicine at Brigham and Women’s Hospital in Boston and was a senior figure at Harvard Medical School, building one of the country’s most influential academic medicine programs.

He was also the founder of the TIMI, or Thrombolysis In Myocardial Infarction, Study Group, whose major trials helped validate or strengthen evidence for a series of treatments that became standard care. Among them were thrombolytic therapy using tPA to dissolve clots, ACE inhibitors to improve outcomes after heart attack and statins to lower cardiovascular risk. The work helped set a model for large, carefully run trials that could quickly change how patients were treated.

Outside the clinic and laboratory, Braunwald had an equally broad impact through medical publishing and education. He was the founding editor and long the lead editor of Braunwald’s Heart Disease, one of cardiology’s standard textbooks. Its 13th edition was published in 2026. He also had a long editorial role with Harrison’s Principles of Internal Medicine, another core text in physician training.

By publisher and institutional counts, Braunwald published more than 1,400 scientific papers. He remained active into his 90s and was still publishing in 2026, including a paper in April, according to the American Heart Association. In 2019, Brigham and Women’s Hospital underscored his stature by naming a 16-story tower in his honor.

Tributes from major medical organizations cast his influence in unusually broad terms. Thomas F. Lüscher, president of the European Society of Cardiology, said: “Professor Braunwald was the leading cardiologist of his time. His vision and innovation changed the trajectory of cardiovascular medicine.”

NHLBI Director David C. Goff said, “The Institute, the NIH, and the field at large is ever beholding to Dr. Eugene Braunwald, a giant of cardiology. May his memory be for a blessing.”

Braunwald’s first wife, Nina Starr Braunwald, a pioneering surgeon, died before him. He is survived by his second wife, Elaine Smith, and daughters, according to the family obituary.